ArticleJournal of clinical and translational research2022

Tumor grade and symptoms at presentation are survival risk factors in Chinese patients with primary retroperitoneal sarcoma.

Aobo Zhuang et al.PubMed ↗Full text ↗

No numbers read from the abstract.